NCT03473743: A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 125 taking part
- Started
- 5 Apr 2018
- Primary completion
- 30 Sep 2022
- Arms
- Phase 1b: Dose Escalation
- Results
- Posted on the registry
- 22 Mar 2018: Trial registered
- 5 Apr 2018: Trial started
- 25 Oct 2023: Trial results posted